
Loading, please wait...

Loading, please wait...

Person-centred HIV prevention focuses on personal preferences and social contexts to improve health outcomes. Consequently, this approach moves away from rigid protocols to address the unique obstacles faced by various populations. A recent scoping review explores these models across sub-Saharan Africa to identify the most effective strategies for engagement.
The review highlights shared decision-making and decentralized delivery as essential components of care. Furthermore, community-based models significantly improve trust and service accessibility. By providing options for prevention methods and locations, healthcare systems can increase satisfaction among marginalized groups. Moreover, integrating psychological safety into clinical settings encourages higher participation rates.
Implementation of person-centred HIV prevention consistently demonstrates improved clinical outcomes and patient retention. In addition, peer-supported initiatives help reach key populations that traditional clinics often overlook. Therefore, these strategies are vital for reaching global health targets and ensuring health equity. Clinics that adopt choice-based models report better adherence to PrEP and antiretroviral therapies.
However, geographical representation remains uneven across the continent. Specifically, West and Central Africa show notable gaps in the adoption of person-centred strategies. Furthermore, adolescents and sexual minorities still face significant equity challenges in various regions. Addressing these structural barriers and psychosocial needs is necessary for achieving long-term success in HIV prevention.
It is a healthcare approach that prioritises individual preferences, social context, and personal needs to improve the delivery and uptake of HIV prevention services.
Peer-led initiatives build community trust and reduce stigma, which significantly improves service accessibility and treatment adherence for key populations.
References
Asogun D et al. Person-centred HIV prevention services in sub-Saharan Africa: a scoping review. AIDS Res Ther. 2026 Feb 05. doi: 10.1186/s12981-025-00839-0. PMID: 41645222.
WHO. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: a person-centred approach. World Health Organization; 2021.
UNAIDS. Differentiated Service Delivery for HIV: A Global Overview. 2023.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


How Person-Centred HIV Prevention Boosts Service UptakePerson-centred HIV prevention focuses on personal preferences and social contexts to improve health o...
6 months ago

A post hoc analysis of the 3-year SURMOUNT-1 trial shows that tirzepatide 15 mg significantly reduces predicted 10-year cardiovascular disease risk (ARR -1.31%, HR 0.62) compared to placebo in adults with obesity and prediabetes, offering durable primary cardiovascular prevention.
Today

A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
Today

A systematic review and meta-analysis of 21 RCTs reveals that exercise snacks significantly improve VO2max and peak power output in adults. While aerobic gains were strongest in adults under 50, power output improved across all ages. Evidence for blood lipids and body fat changes remains inconsistent.
Today

A ten-year review highlights how preclinical time-lapse micro-CT and synchrotron imaging allow dynamic tracking of cortical bone porosity and remodeling space kinetics. Recent studies reveal how therapeutic agents like PTH and glucocorticoids alter linear erosion rates and pore morphology.
Today

A study demonstrates that gomisin N (25 µM) protects MIN6 pancreatic beta-cells by alleviating endoplasmic reticulum and oxidative stress induced by CPA. By reducing ROS levels and promoting correct proinsulin folding, gomisin N restores insulin secretion and beta-cell viability in diabetes models.
Today